INDmoney
Takeda Pharmaceutical Company Limited Stock Performance
as on February 14, 2026 at 7:59 am IST
Day's Low
Day's High
$18.36$18.50
0.65%
Downside
0.11%
Upside
52 Week's Low
52 Week's High
$12.99$18.4529.71%
Downside
-0.16%
Upside
Takeda Pharmaceutical Company Limited share price movements today
- Previous Close
- $18.37
- Open
- $18.37
- Volume
- 3.3M
- Day's Low - High
- $18.36 - $18.50
- 52 Week Low - High
- $12.99 - $18.45
Takeda Pharmaceutical Company Limited Historical Returns
- 1 Month Return
- + 14.74 %
- 3 Month Return
- + 29 %
- 1 Year Return
- + 34.88 %
- 3 Year Return
- + 15.46 %
- 5 Year Return
- + 4.73 %
Takeda Pharmaceutical Company Limited Stock Fundamentals & Key Indicators
Check Takeda Pharmaceutical Company Limited market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$57.8B
EPS (TTM)
51.162
Dividend Yield
4.05%
Quarterly Earnings Growth YOY
3.30%
PE Ratio (TTM)
79.48
Industry PE ratio
19.926794871794872
PEG Ratio
0.3981
EBITDA
1.3T
Revenue (TTM)
4.5T
Profit Margin
2.53%
Return On Equity TTM
1.50%
Takeda Pharmaceutical Company Limited Stock Valuation
Track how Takeda Pharmaceutical Company Limited P/E has moved over time to understand its valuation trends.
Takeda Pharmaceutical Company Limited in the last 5 years
Lowest (0.08x)
June 30, 2025
Industry (19.93x)
February 13, 2026
Today (79.48x)
February 13, 2026
Highest (1.14x)
September 30, 2023
Today’s Price to Earnings Ratio: 79.48x
Takeda Pharmaceutical Company Limited vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Takeda Pharmaceutical Company Limited with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $57.8B | 4.73% | 79.48 | 2.53% | |
| BUY | $21.5B | NA | 18.06 | 40.65% | |
| BUY | $49.7B | NA | 24.26 | 13.81% | |
| HOLD | $18.6B | -13.43% | -21.95 | -26.13% | |
| BUY | $57.0B | -24.64% | 21.55 | 28.21% |
Stock Returns calculator for Takeda Pharmaceutical Company Limited Stock including INR - Dollar returns
The Takeda Pharmaceutical Company Limited stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Takeda Pharmaceutical Company Limited investment value today
Current value as on today
₹1,40,312
Returns
₹40,312
(+40.31%)
Returns from Takeda Pharmaceutical Company Limited Stock
₹35,683 (+35.68%)
Dollar Returns*
₹4,629 (+4.63%)
Analyst Recommendation on Takeda Pharmaceutical Company Limited Stock
Based on 23 analysts
52.17%
Buy
47.83%
Hold
0.00%
Sell
Based on 23 analysts, 52.17% of analysts recommend a 'BUY' rating for Takeda Pharmaceutical Company Limited. Average target price of $19.11
Takeda Pharmaceutical Company Limited Share Price Target
Get share price movements and forecasts by analysts on Takeda Pharmaceutical Company Limited.
What analysts predicted
3.3%UPSIDE
Target Price
$19.11
Current Price
$18.48
Analyzed by
23 Analysts
Target
$19.11
Takeda Pharmaceutical Company Limited target price $19.11, a slight upside of 3.3% compared to current price of $18.48. According to 23 analysts rating.
Takeda Pharmaceutical Company Limited Stock’s Investor Sentiment and Interest
Search interest for Takeda Pharmaceutical Company Limited Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:28% versus previous 30 day period
Takeda Pharmaceutical Company Limited Quarterly Profit & Loss
All numbers in Millions USD
Takeda Pharmaceutical Company Limited Annual Profit & Loss
All numbers in Millions USD
Takeda Pharmaceutical Company Limited Quarterly Cash Flow
All numbers in Millions USD
Takeda Pharmaceutical Company Limited Annual Cash Flow
All numbers in Millions USD
Takeda Pharmaceutical Company Limited News & Key Events
Today's Timeline - 21 October
Tue, 03:23 PM
-Takeda signs research partnership with Nabla Bio to enhance AI-driven drug delivery and design protein-based treatments.
Wed, 05:55 AM
-Takeda partners with Innovent Biologics to co-develop and commercialize late-stage oncology medicines globally, excluding Greater China and the U.S.
Insights on Takeda Pharmaceutical Company Limited
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Takeda Pharmaceutical Company Limited has shown strong revenue growth over the last four quarters. Revenue increased from $1,053.4 billion to $1,213.21 billion, indicating a consistent upward trend. On average, the company has experienced a revenue increase of 4.6% each quarter.
- POSITIVE IMPACT
Profit Spike
Takeda Pharmaceutical Company Limited has shown strong profit growth over the last two quarters. The net profit increased significantly from -11.80 billion dollars to 105.50 billion dollars, averaging a growth rate of 111.2% per quarter.
- POSITIVE IMPACT
Price Rise
In the last 7 days, TAK stock has moved up by 2.7%
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation has given 33.2% return, outperforming this stock by 15.9%
- NO EFFECT
Against Peers
In the last 1 year, Viatris Inc. has given 46.2% return, outperforming this stock by 10.5%
About Takeda Pharmaceutical Company Limited
| Organisation | Takeda Pharmaceutical Company Limited |
| Headquarters | 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 |
| Industry | Health Technology |
| CEO | Mr. Christophe Weber |
| E-voting on shares | Click here to vote |
Key Management of Takeda Pharmaceutical Company Limited
Name | Title |
|---|---|
Mr. Christopher David O'Reilly | Global Head of Investor Relations & Global Finance |
Mr. Christophe Weber | President, CEO & Representative Director |
Mr. Milano Furuta | CFO & Director |
Mr. Haruhiko Hirate | Member of Management Board |
Mr. Salvatore Alesci M.D., Ph.D. | Member of Management Board and Head of R&D Global Science & Biomedical Policy |
Norimasa Takeda | Chief Accounting Officer & Corporate Controller |
Mr. Iwaaki Taniguchi | Senior Vice President of Corporate Finance & Controlling Department |
Mr. Gabriele Ricci | Chief Data & Technology Officer |
Dr. Andrew S. Plump M.D., Ph.D. | President of Research & Development and Representative Director |
Dr. Seigo Izumo | Chair of Management Board |
FAQs
What is Takeda Pharmaceutical Company Limited share price today?
Takeda Pharmaceutical Company Limited share price today is $18.48 as on at the close of the market. Takeda Pharmaceutical Company Limited share today touched a day high of $18.5 and a low of $18.36.
What is the 52 week high and 52 week low for Takeda Pharmaceutical Company Limited share?
Takeda Pharmaceutical Company Limited share touched a 52 week high of $18.45 on and a 52 week low of $12.99 on . Takeda Pharmaceutical Company Limited stock price today i.e. is closed at $18.48,which is -0.16% down from its 52 week high and 42.26% up from its 52 week low.
What is Takeda Pharmaceutical Company Limited's market capitalisation today?
Takeda Pharmaceutical Company Limited market capitalisation is $0.06T as on .
How to invest in Takeda Pharmaceutical Company Limited Stock (TAK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Takeda Pharmaceutical Company Limited on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Takeda Pharmaceutical Company Limited Shares that will get you 0.0812 shares as per Takeda Pharmaceutical Company Limited share price of $18.48 per share as on February 14, 2026 at 2:29 am IST.
What is the minimum amount required to buy Takeda Pharmaceutical Company Limited Stock (TAK) from India?
Indian investors can start investing in Takeda Pharmaceutical Company Limited (TAK) shares with as little as ₹90.64 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.40 in Takeda Pharmaceutical Company Limited stock (as per the Rupee-Dollar exchange rate as on ).
Based on Takeda Pharmaceutical Company Limited share’s latest price of $18.48 as on February 14, 2026 at 2:29 am IST, you will get 0.5411 shares of Takeda Pharmaceutical Company Limited. Learn more about
fractional shares .
What are the returns that Takeda Pharmaceutical Company Limited has given to Indian investors in the last 5 years?
Takeda Pharmaceutical Company Limited stock has given 4.73% share price returns and 24.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?